CompletedPhase 3ACTRN12605000461695

The value of GP endorsement on participation in rescreening for colorectal cancer


Sponsor

Prof. Graeme Young MD, FRACP

Enrollment

2,400 participants

Start Date

Dec 6, 2000

Study Type

Interventional

Conditions

Summary

Improved participation in screening for bowel cancer is desirable. Large scale screening programs must recruit invitees through comprehensive population registers. Depending on the country and health system these may be primary care practice lists or other registers such as the electoral roll. If primary care patient lists are available, considerable practice time may be required to organise the screening program, alternatively the implicit practice endorsement of screening may increase the participation rate to make that investment worthwhile. As screening is most effective when conducted regularly, it is important to determine if any increase in participation rate due to practice or practitioner endorsement is maintained over several rounds of screening offers. This study aims to follow screening participation over 4 rounds of offers in 4 treatment groups, and to use innovative statistical methods to determine the value of practice involvement in re-sceening participation.


Eligibility

Sex: Both males and femalesMin Age: 50 YearssMax Age: 80 Yearss

Plain Language Summary

Simplified for easier understanding

This study examines whether having a GP (family doctor) endorse a colorectal cancer screening program increases participation in re-screening. Adults aged 50 to 80 on participating GP patient lists are eligible. Participation involves receiving a screening invitation and completing a bowel cancer screening test.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

The aim is to determine the value of GP endorsement for faecal occult blood test based re-screening colorectal cancer. The interventions are conducted within the setting of a population screening prog

The aim is to determine the value of GP endorsement for faecal occult blood test based re-screening colorectal cancer. The interventions are conducted within the setting of a population screening program where invitees are recruited from general practice patient lists. Intervention 1: Invitation letter to re-screen on central screening facility letterhead with statement from invitee's general practice endorsing participation in screening, signed by screening coordinator. Intervention 2: Invitation letter to rescreen on practice letterhead with statement from practice endorsing screening, signed by invitee's general practitioner. Comparison group: recruited from electoral roll receiving control invitation to rescreen. Duration: Four annual rounds of screening offers. All people received the same invitation type over the 4 rounds of screening invitations.


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12605000461695